B. Németh

发表

The transferability of health technology assessment: the European perspective with focus on central and Eastern European countries

M. Huic, Z. Kaló, W. Goettsch, 2020, Expert review of pharmacoeconomics & outcomes research.

Navigating joint HTA, procurement, and fair pricing: evidence-based insights and practical recommendations - A meeting report from ISPOR regional conference in Warsaw, 2019

A. Inotai, B. Németh, 2019, Expert review of pharmacoeconomics & outcomes research.

EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE

O. Oyebode, Z. Garrett, A. Cangini, 2015, International Journal of Technology Assessment in Health Care.

Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?

Sandor J. Kovacs, Z. Kaló, V. Brodszky, 2022, Applied Health Economics and Health Policy.

Using real-world evidence in healthcare from Western to Central and Eastern Europe: a review of existing barriers.

M. Kamusheva, Z. Kaló, Jamie Elvidge, 2022, Journal of comparative effectiveness research.

Barriers to Use Artificial Intelligence Methodologies in Health Technology Assessment in Central and East European Countries

M. Kamusheva, G. Petrova, Z. Kaló, 2022, Frontiers in public health.

Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries

M. Kamusheva, Z. Kaló, D. Dawoud, 2022, Frontiers in Public Health.

Using informative prior based on expert opinion in Bayesian estimation of the transition probability matrix in Markov modelling—an example from the cost-effectiveness analysis of the treatment of patients with predominantly negative symptoms of schizophrenia with cariprazine

I. Bitter, J. Réthelyi, Z. Vokó, 2020, Cost Effectiveness and Resource Allocation.

Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives

Z. Kaló, O. Piniazhko, A. Inotai, 2019, International Journal of Technology Assessment in Health Care.

S0266462319000679jra 393..400

Z. Kaló, O. Piniazhko, A. Inotai, 2019 .

Reimbursement and payment models in Central and Eastern European as well as Middle Eastern countries: a survey of their current use and future outlook.

Z. Kaló, W. Goettsch, R. Vreman, 2022, Drug discovery today.

Systematic literature review of health economic models developed for multiple myeloma to support future analyses.

D. Hose, P. Keown, J. Harousseau, 2022, Journal of medical economics.

Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone.

Bertalan Németh, Ron Akehurst, Margit Horváth, 2017, Journal of comparative effectiveness research.

Unusual form of sialolithiasis: case report with 3-dimensional imaging.

Z. Németh, B. Németh, T. Würsching, 2016, British Journal of Oral and Maxillofacial Surgery.

Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low- and middle-income countries.

András Inotai, Zoltán Kaló, Bertalan Németh, 2019, Journal of comparative effectiveness research.

Can cost–effectiveness principles be ignored in urgent times?

Z. Kaló, A. Zemplényi, B. Németh, 2021, Journal of comparative effectiveness research.

Cost‐effectiveness of alternative smoking cessation scenarios in Spain: results from the EQUIPTMOD

D. Coyle, K. Coyle, K. Cheung, 2018, Addiction.

A systematic review of health economic models and utility estimation methods in schizophrenia

I. Bitter, B. Nagy, B. Németh, 2018, Expert review of pharmacoeconomics & outcomes research.

Drug Policy in Hungary.

A. Harsányi, A. Inotai, M. Csanádi, 2017, Value in health regional issues.

OVERVIEW ON THE CURRENT IMPLEMENTATION OF HEALTH TECHNOLOGY ASSESSMENT IN THE HEALTHCARE SYSTEM IN HUNGARY

Z. Kaló, M. Csanádi, B. Németh, 2017, International Journal of Technology Assessment in Health Care.

Drug Policy in Central Eastern Europe—Hungary

A. Harsányi, A. Inotai, M. Csanádi, 2017 .

Potential Criteria for Frameworks to Support the Evaluation of Innovative Medicines in Upper Middle-Income Countries—A Systematic Literature Review on Value Frameworks and Multi-Criteria Decision Analyses

Hakan Tozan, Bertalan Németh, Jie Shen, 2020, Frontiers in Pharmacology.

European cooperation in health technology assessment implementation: the perspective of Central and Eastern European countries.

Z. Kaló, B. Németh, 2020, Journal of comparative effectiveness research.

A systematic review of the indirect costs of schizophrenia in Europe

Z. Kaló, B. Németh, K. Kóczián, 2018, European journal of public health.

Framework for Patient Experience Value Elements in Rare Disease: A Case Study Demonstrating the Applicability of Combined Qualitative and Quantitative Methods

R. McQueen, K. Nair, Z. Kaló, 2022, PharmacoEconomics - Open.

Cost‐effectiveness of possible future smoking cessation strategies in Hungary: results from the EQUIPTMOD

K. Coyle, K. Cheung, Z. Vokó, 2018, Addiction.

Development of multi-criteria decision analysis (MCDA) framework for off-patent pharmaceuticals – an application on improving tender decision making in Indonesia

Bertalan Németh, Andras Inotai, Iwan Dwiprahasto, 2018, BMC Health Services Research.

Cost‐effectiveness of increasing the reach of smoking cessation interventions in Germany: results from the EQUIPTMOD

D. Coyle, K. Coyle, K. Cheung, 2017, Addiction.

Guidance toward the implementation of multicriteria decision analysis framework in developing countries

András Inotai, Zoltán Kaló, Bertalan Németh, 2018, Expert review of pharmacoeconomics & outcomes research.

Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations

Z. Kaló, D. Dawoud, W. Goettsch, 2023, International Journal of Technology Assessment in Health Care.

Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19

Saskia Knies, Zoltán Kaló, Dalia Dawoud, 2021 .

Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model

D. Coyle, M. Huic, K. Coyle, 2016 .

A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt

Z. Kaló, B. Németh, A. Fasseeh, 2022, BMC Medical Informatics and Decision Making.

Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment

G. Petrova, L. Balkányi, R. Hren, 2023, Frontiers in Public Health.

Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making

M. Kamusheva, L. Balkányi, R. Hren, 2023, Journal of comparative effectiveness research.

Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer

Z. Kaló, B. Nagy, M. Wawruch, 2017, Front. Pharmacol..

Development and application of an economic model (EQUIPTMOD) to assess the impact of smoking cessation

M. Hiligsmann, D. Coyle, R. West, 2017, Addiction.

Outcome-based reimbursement in Central-Eastern Europe and Middle-East

Z. Kaló, D. Dawoud, R. Kahveci, 2022, Frontiers in Medicine.

Delayed payment schemes in Central-Eastern Europe and Middle-East

Z. Kaló, D. Dawoud, W. Goettsch, 2022, Frontiers in Medicine.

Cost-utility analysis of cariprazine compared to risperidone among patients with negative symptoms of schizophrenia

Z. Kaló, B. Nagy, B. Németh, 2019, Health Policy and Technology.

Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe.

J. Pitter, B. Németh, Antal Zemplényi, 2023, GeroScience.

Country score tool to assess readiness and guide evidence generation of immunization programs in aging adults in Europe

M. Postma, C. de Waure, D. Salisbury, 2023, Frontiers in Public Health.

Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)

J. Chhatwal, Jaakko Suutala, R. Pwu, 2024, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

A utility of model input uncertainty analysis in transferring tobacco control‐related economic evidence to countries with scarce resources: results from the EQUIPT study

D. Coyle, M. Huic, K. Coyle, 2018, Addiction.